Stemina Launches Autism Clinical Study
 /  News / Stemina Launches Autism Clinical Study

Stemina Launches Autism Clinical Study

Stemina Biomarker Discovery Inc. today announced the launch of the largest clinical study of the metabolism of children with autism spectrum disorder (ASD) ever conducted. The Children’s Autism Metabolome Project or “CAMP” study will enroll 1,500 subjects from six sites across the country. CAMP will attempt to confirm that sets of metabolic biomarkers can detect subtypes of ASD.

Learn More

Related Posts

(608) 204-0104

504 S. Rosa Rd. Suite 150
Madison, WI 53719

contact@NeuroPointDx.com